Maccon Keane
Impact in
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Oncology top 2%
- Bone health and treatments
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Oncology 30
- Cancer Treatment and Pharmacology 10
- Bone health and treatments 7
- HER2/EGFR in Cancer Research 4
-
- Breast Cancer Treatment Studies 17
- NF-κB Signaling Pathways 6
- Co-authors
- Seth A. Ettenberg (8 shared papers)Marion M. Nau (6 shared papers)Stan Lipkowitz (6 shared papers)E K Russell (2 shared papers)Stanley Lipkowitz (5 shared papers)Mauricio Cuello (3 shared papers)Éva Szegezdi (4 shared papers)Devalingam Mahalingam (4 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Breast Cancer Research and Treatment (6 papers)Cancer Research (5 papers)European Journal of Cancer (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Maccon Keane
72 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 831
- Oncology 1.4k
- Internal Medicine 100
- Immunology 597
- Molecular Biology 1.8k
Countries citing papers authored by Maccon Keane
This map shows the geographic impact of Maccon Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maccon Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maccon Keane more than expected).
Fields of papers citing papers by Maccon Keane
This network shows the impact of papers produced by Maccon Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maccon Keane. The network helps show where Maccon Keane may publish in the future.
Co-authors
The 25 scholars most cited alongside Maccon Keane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. | 1999 | 499 |
| 2 | Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. | 2001 | 310 |
| 3 | 2008 | 238 | |
| 4 | Fas expression and function in normal and malignant breast cell lines. | 1996 | 223 |
| 5 | 2014 | 216 | |
| 6 | 2000 | 190 | |
| 7 | 2010 | 171 | |
| 8 | 2013 | 139 | |
| 9 | The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. | 1996 | 116 |
| 10 | 2017 | 113 | |
| 11 | 1999 | 105 | |
| 12 | 2007 | 104 | |
| 13 | 1999 | 99 | |
| 14 | 2011 | 98 | |
| 15 | 2000 | 93 | |
| 16 | 2018 | 85 | |
| 17 | 2017 | 78 | |
| 18 | 2014 | 65 | |
| 19 | 2010 | 48 | |
| 20 | 1999 | 48 |
About Maccon Keane
Maccon Keane is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 74 papers that have together received 3.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Cancer Treatment and Pharmacology (10 papers), Cell death mechanisms and regulation (9 papers), Advanced Breast Cancer Therapies (9 papers), Bone health and treatments (7 papers), NF-κB Signaling Pathways (6 papers), Lung Cancer Treatments and Mutations (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (831 citations), Oncology (1.4k citations), Internal Medicine (100 citations), Immunology (597 citations) and Molecular Biology (1.8k citations). Maccon Keane has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Seth A. Ettenberg, Marion M. Nau, Stan Lipkowitz, E K Russell, Stanley Lipkowitz, Mauricio Cuello, Éva Szegezdi, Devalingam Mahalingam, Afshin Samali and Steven de Jong. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.